| __timestamp | ImmunityBio, Inc. | Novartis AG |
|---|---|---|
| Wednesday, January 1, 2014 | 1595000 | 9086000000 |
| Thursday, January 1, 2015 | 11434000 | 8935000000 |
| Friday, January 1, 2016 | 26546000 | 9039000000 |
| Sunday, January 1, 2017 | 39778000 | 8972000000 |
| Monday, January 1, 2018 | 53418000 | 9074000000 |
| Tuesday, January 1, 2019 | 111997000 | 9402000000 |
| Wednesday, January 1, 2020 | 139507000 | 8980000000 |
| Friday, January 1, 2021 | 195958000 | 9540000000 |
| Saturday, January 1, 2022 | 248149000 | 9996000000 |
| Sunday, January 1, 2023 | 232366000 | 11371000000 |
| Monday, January 1, 2024 | 10022000000 |
Unleashing insights
In the ever-evolving landscape of biotechnology and pharmaceuticals, innovation is the key to staying ahead. Over the past decade, Novartis AG and ImmunityBio, Inc. have been at the forefront of this race, investing heavily in research and development (R&D). From 2014 to 2023, Novartis AG consistently outpaced ImmunityBio, Inc. in R&D spending, with an average annual investment nearly 90 times greater. In 2023, Novartis AG allocated approximately $11.4 billion, marking a 25% increase from 2014, while ImmunityBio, Inc. reached its peak investment of around $232 million, a staggering 145-fold increase from its 2014 figures. This substantial growth in ImmunityBio's R&D spending highlights its commitment to innovation, despite being dwarfed by Novartis's financial prowess. As the industry continues to evolve, these investments will likely shape the future of healthcare and treatment breakthroughs.
R&D Insights: How Novartis AG and Summit Therapeutics Inc. Allocate Funds
R&D Spending Showdown: Novartis AG vs Sarepta Therapeutics, Inc.
Research and Development Investment: Novartis AG vs Madrigal Pharmaceuticals, Inc.
Comparing Innovation Spending: Novartis AG and PTC Therapeutics, Inc.
Research and Development Investment: Amgen Inc. vs ImmunityBio, Inc.
Research and Development Expenses Breakdown: Vertex Pharmaceuticals Incorporated vs ImmunityBio, Inc.
R&D Spending Showdown: Dr. Reddy's Laboratories Limited vs ImmunityBio, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Ascendis Pharma A/S and ImmunityBio, Inc.
Research and Development: Comparing Key Metrics for Jazz Pharmaceuticals plc and ImmunityBio, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Verona Pharma plc and ImmunityBio, Inc.
Research and Development Investment: Arrowhead Pharmaceuticals, Inc. vs ImmunityBio, Inc.
R&D Insights: How ImmunityBio, Inc. and MannKind Corporation Allocate Funds